NCT06055439 2026-01-29A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell TherapyChimeric TherapeuticsPhase 1/2 Recruiting135 enrolled
NCT06943521 2025-12-11A Study of MT-4561 in Patients With Various Advanced Solid TumorsTanabe Pharma America, Inc.Phase 1/2 Recruiting27 enrolled
NCT02611024 2025-07-09Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsPharmaMarPhase 1/2 Completed316 enrolled
NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts